AACR 2017: Combination of nivolumab and ipilimumab improved overall survival for advanced melanoma patients
Among patients with advanced melanoma, those who received both nivolumab (Opdivo) and ipilimumab (Yervoy) had…
Trending
- Making Telehealth Human – Podcast
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- Potential therapeutic targets to inhibit colorectal cancer progression
- UK Lockdowns: Significant reduction in new cancer diagnoses
- More than half of cancer survivors have underlying medical conditions associated with severe COVID
- Providing inclusive care for LGBTQ2SPIA cancer patients
- Breast cancer-on-a-chip for testing immunotherapy drugs
- Study shows aspirin before a diagnosis may lower colorectal cancer mortality
- Imaging identifies breast cancer patients unlikely to benefit from hormone therapy
- Hypoxia reprograms methylation of ribosomal RNAs
